HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014-Reference-Cited by-同舟云学术

HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014

Published:2017-02-16 Issue:2 Volume:12 Page:e0171227
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Häggblom Amanda,Lindbäck Stefan,Gisslén Magnus,Flamholc Leo,Hejdeman Bo,Palmborg Andreas,Leval Amy,Herweijer Eva,Valgardsson Sverrir,Svedhem Veronica

Funder

AbbVie Nordic

AbbVie (US)

Gilead Sciences (US)

GlaxoSmithKline/ViiV

Gilead Nordic

Läkare mot AIDS

Stockholms Läns Landsting (SE)

Gilead Nordic Fellowship Program

Merk SharpDohme

Boehringer-Ingelheim

Bristol-Myers Squibb

Janssen-Cilag

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. The effect of combined antiretroviral therapy on the overall mortality of HIV infected individuals;M Ray;AIDS,2010

2. Transmission of HIV drug Resistance and the Predicted Effect on Current First-line Regimens in Europe;LM Hofstra;Clin Infect Dis,2016

3. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis;C Ortego;AIDS Behav,2011

4. University of Liverpool HIV Drug Interaction Website. Available from: http://www.hiv-druginteractions.org/

5. The Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents. Available from: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv-guidelines/31/adverse-effects-of-arv

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan;Journal of Infection and Chemotherapy;2022-11

2. Real-World Characterization of the Portuguese Population Living with HIV who Initiated Raltegravir Based-Regimens: The REALITY Study;Acta Médica Portuguesa;2022-07-01

3. Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV;AIDS Research and Human Retroviruses;2022-06-01

4. Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies;Antiviral Therapy;2021-11

5. High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden;AIDS;2021-02-02